Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Binimetinib in Combination With Imatinib in Patients With Advanced KIT-Mutant Melanoma

NCT04598009 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT04598009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04598009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Binimetinib in Combination With Imatinib in Patients With Advanced KIT-Mutant Melanoma
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Recruiting
Start date
March 3, 2021
Completion date
May 31, 2028
Enrollment
25 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma stage iii, melanoma stage iv